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Protelnuria, hematurla, and leukocyturia in children with mixed
urinary and intestinal schistosomiasis. Quantitative parasitological as-
sessment and quantitative analysis of proteinuria, hematuria, and
leukocyturia were carried out in 182 Sudanese schoolboys with mixed
urinary and intestinal schistosomiasis. Pathological proteinuria was
found in 73% of patients (median = 380, 95% confidence limits = 200 to
500 mg/liter). The median protein/creatinine ratio was 0.54. SDS
polyacrylamide gel electrophoresis showed an excretion of albumin,
transferrin, and IgG consistent with a postrenal pattern of proteinuria.
Pathological erythrocyturia occurred in 84% of patients (median = 255,
95% CL = 95 to 629 cel1s/s1) and leukocyturia in 77% of patients
(median = 148, 95% CL = 93 to 246 cells/pi). Phase contrast micros-
copy revealed intact erythrocytes, suggestive of postrenal hemorrhage.
Proteinuria, erythrocyturia, and leukocyturia correlated significantly
with the ova excretion in the urine, but not with egg excretion in the
stool. Oxamniquine reduced ova excretion in the stool but did not
influence pathological urine findings. In patients treated effectively with
Praziquantel or Metrifonate, pathological PU, EU, and LU decreased
markedly I month post treatment. PU in severely proteinuric patients
reached physiological values 5 months post therapy. We suggest that
the proteinuria, erythrocyturia, and leukocyturia in mixed schistosomi-
asis were of postrenal origin.
Protéinurle, hématurie, et leucocyturie chez des enfants atteints de
schistosomiase mixte urinaire et intestinale. Une evaluation quantitative
parasitaire et une analyse quantitative de Ia protéinurie, de l'hématurie,
et de La leucocyturie ont eté effectuées chez 182 écoliers soudanais
atteints de schistosomiase mixte urinaire et intestinale. Une protéinurie
pathologique a éte trouvée chez 73% des malades (mediane = 380,
intervalle de confiance 95% = 200 fi 500 mg/litre). Le rapport median
protCine/créatinine Ctait de 0.54. Une électrophorese sur gel de
polyacrylamide-SDS a montré une excretion d'albumine, de transfer-
rine, et d'lgG compatibles avec un aspect post'renal de Ia protéinurie.
Une erythrocyturie pathologique Ctait présente chez 84% des malades
(mediane = 225, 95% CL = 95 it 629 cellules/td) et une leucocyturie
chez 77% des malades (mediane = 148, 95% CL = 93 a 246 cellules/.d).
La microscopic en contraste de phase a révélé des érythrocytes intacts,
suggCrant une hémorragie post-rCnale. La protéinurie, l'erythrocyturie,
et Ia leucocyturie étaient significativement corrClées it l'excrCtion
d'oeufs dans les urines, mais non avec L'excrétion d'oeufs dans les
selles. L'oxamniquine a rCduit l'excrétion d'oeufs dans les selles mais
n'a pas influence les anomalies urinaires. Chez des malades traitCs
efficacement avec du Praziquantel ott du Métrifonate, PU, EU, et LU
pathologiques ont diminué de facon marquee un mois aprCs le traite-
ment. PU chez les malades sevérement protCinuriques a atteint des
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valeurs physiologiques 5 mois aprCs le traitement. Ces résultats sugger-
ent que Ia protéinurie, I'Crythocyturie, et Ia leucocyturie dans La
schistosomaise mixte Ctiaent d'origine post'rénale.
Pathological urine findings such as proteinuna (PU),
leukocyturia (LU), and erythrocyturia (EU) have been known
to be associated with urinary schistosomiasis since the early
description of the disease [1]. Most studies comparing ova
output and pathological urine findings have only used test strip
analysis for PU, EU, and LU [2—4]. Thus, in this study, the
prevalence of PU, EU, and LU in patients with schistosomiasis
was investigated by quantitative techniques. To assess the
influence of ova excretion in both urine and stool on patholog-
ical urine findings, patients suffering from mixed Schistosoma
haematobium and mansoni infection were chosen. The
reversibility of pathological urine findings was assessed after
treatment with Praziquantel, Metrifonate, or Oxamniquine,
which exert different effects on S. haematobium and S. man-
soni ova output.
Previous studies support the hypothesis that pathological
urine findings have a postrenal origin [3, 5]. In contrast, other
authors have raised doubts about the postrenal origin of PU [6]
and consider renal lesions to be responsible for PU [7—9]. In this
study, qualitative analysis of urinary proteins according to their
molecular weight and phase contrast microscopy of erythro-
cytes were carried out to determine the origin of PU and EU.
Methods
Study area and patients
The investigations were conducted in Heibeika, a village in
the Gezira-irrigated area of the Sudan. This region is known to
be highly endemic for Schistosomiasis haematobium and
mansoni [10].
One-hundred eighty-two patients with an age range of 6 to 13
years who presented with a mixed S. haematobium and
mansoni infection were admitted to the study.
Informed consent. Informed consent was obtained in the
Arabic language through parents or family representatives at an
introductory assembly.
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Clinical and blood investigations. All patients underwent a com-
plete physical examination. Thick and thinblood smears were done,
and the hematocrit was determined by a battery-operated hematocrit
centrifuge. Serum specimens were kept at a temperature of —20°C
and investigated later for electrolytes, creatinine, BUN, total protein,
and cholesterol by routine methods.
Urine and stool collections. At 11:00 A. M. all patients re-
ceived a 250 ml soda drink to minimize day-to-day variation of
ova output [11]. Urine was collected under surveillance 45 mm
later. After that, the patients were instructed to deliver a stool
specimen for parasitological examination.
Urine examination. After reagent strip analysis (Combur 9,
Boehringer, Mannheim, Federal Republic of Germany), egg
excretion in the urine was determined quantitatively on 3
consecutive days using the filtration-trypan-blue-staining tech-
nique [12].
Using a Neubauer Chamber, quantitative analyses of eryth-
rocyte and leukocyte counts per jsl urine were carried out
within 1 hr after the voiding of urine on 2 consecutive days. A
phase contrast microscope was used to assess erythrocyte
morphology according to the criteria published by Birch et al
[13].
To measure PU, aliquots of urine were centrifuged. A 2 ml
sample was deep-frozen and kept at a temperature of —20°C
until processed in Germany 4 wks later. Proteinuria was deter-
mined quantitatively by the Coomassie blue-dye binding test
[14].
Qualitative characterization of urinary proteins according to
their molecular weight was achieved in unconcentrated urine
specimens by SDS polyacrylamide gel electrophoresis [15]. The
protein/creatinine ratio was calculated from urinary protein
(mg/liter) and creatinine concentration (mg/liter), PU in excess
of 100 mg/liter and a protein/creatinine ratio of more than 0.2
were considered to be pathological [161. More than 5 erythro-
cytes and 20 leukocytes/pi of urine were regarded as abnormal.
Stool examination. Ova excretion in the stool was quantified
using a modification of the Kato thick smear technique [17].
Three thick smears were prepared on each of the 3 consecutive
days. Results were expressed as number of ova per g stool.
Treatment. Patients were allotted at random to 4 different
groups. Group A was treated with a single dose of Praziquantel
(40 mg/kg); Group B with Metrifonate (twice in a dose of 10
mg/kg with a 2-wk interval), and Group C with a single dose of
Oxamniquine (60 mg/kg). Group D received a multivitamin
tablet as placebo. Those children still excreting viable ova at the
end of the study were treated with Praziquantel (40 mg/kg). All
patients received a complete tetanus vaccination.
Control Group. Since the prevalence of infection in Heibeika
was very high in the age group under investigation, 17 male
students were chosen from a neighboring village 20 km away.
Ova output in those students was excluded by repeated thor-
ough parasitological examinations.
Statistical evaluation
The medians of urinary ova output and PU were calculated
for each patient from urine samples collected on 3 consecutive
days.
Accordingly, medians of EU and LU were calculated from 2
urine samples. Medians of median individual urinary findings
Table 1. Percentage of patients with mixed schistosomiasis and
pathological urine findings
Infected
children
N=182
Non-infected
children
N=17
Proteinuria,
> 100 mg/liter 133/182 (73.1%) 0/17
Protein/creatinine ratio,
> 0.2 13 1/182 (72%) Not Done
Erythrocyturia,
> 5 per pi 153/182 (84.1%) 1/17
Leukocyturia,
> 20 per s1 140/182 (76.9%) 0/17
Ova excretion in urine
and stool 182/182 (100%) 0/17
were computed from the whole study group and 95% confidence
limits (95% CL) as well as ranges were given.
Progression analysis was carried out after transformation of
data from individual urine specimens according to the formula
x' = log (x + 1).
The non-parametric Wilcoxon matched-pairs signed rank test
was used to assess the significance of differences, where
appropriate.
Results
Physical examination was uneventful except for two cases of
moderate splenomegaly. The patients were not anemic and no
malaria parasites were detected in the blood. Serum creatinine,
BUN, and electrolytes were within normal limits, as were
serum protein and cholesterol. Urinary test reagent strips
revealed nitrite excretion in only two cases.
Abnormal proteinuria was found in 73.1% of patients. Patho-
logical hematuria occurred in 84.1% and leukocyturia in 76.9%
(Table I). Except for one case of microhematuria, physiological
values were found in the control group (Table 1). Median ova
output in the urine was 84.4 per 10 ml (range = 0.1 to 9009).
Median ova excretion per g stool was 680 (range = 8 to 4849).
Accordingly, a marked pathological PU was found (median of
urinary protein concentration 0.38 g/liter, range = 0.02 to
6.37; median protein/creatinine ratio = 0.54, range = 0.02 to
8.15). Median EU was 255 cells per jd (range = 0 to 35,568) and
median LU 148 cells per l of urine (range = 0 to 7,632). There
was a significant correlation between PU, EU and LU with ova
excretion in the urine (Fig. 1). The correlation coefficients were
0.86 for PU and 0.84 and 0.83 for EU and LU. In contrast, there
was no significant correlation between pathological urine find-
ings and ova output in the stool.
In all patients with a PU of more than 100 mg/liter, qualitative
electrophoretic assessment of urinary proteins exhibited a high
molecular weight pattern consisting mainly of albumin, trans-
ferrin, and IgG (Fig. 2). The albumin/transferrin ratio was
similar to that in the serum. A protein band of about 45,000
daltons appeared in most of the electrophoreses carried out.
The protein pattern resembled the one found in the serum. Low
molecular weight proteins such as a 1 microglobulin, lysozyme
or f3 2 microglobulin were absent in all patients studied. A
protein band of 15,000 daltons could be identified as hemoglobin
chains. Phase contrast microscopy of EU revealed normal disc
forms indicating postrenal bleeding. Deformed erythrocytes,
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urine findings reversed after treatment with Praziquantel and
Metrifonate (Table 2). PU, EU, and LU were within physiolog-
ical limits 1 month alter therapy with Praziquantel. After
Metrifonate treatment, there was a marked decrease in patho-
logical urine findings, but no return to physiological values. In
contrast, no significant reduction in urinary egg output and
urine findings occurred after treatment with Oxamniquine or
placebo.
Table 3 depicts those patients who had a high PU before
therapy, that is, in excess of 1 g/liter and who were effectively
— 0 86 treated for S. haematobium ova excretion in the urine.Median ova excretion was 1,257 per 10 ml before treatment
and decreased to 5.4 and 2.8, 1 and 5 months post therapy,
respectively. PU, EU, and LU I month post treatment were
___________________________________________ reduced drastically, but were still markedly pathological despite
almost negligible ova excretion at that point in time. PU
reached physiological values 5 months post treatment.
Discussion
Patients with urinary schistosomiasis frequently have patho-
logical proteinuria, hematuria, and leukocyturia [2, 18, 19]. The
previously reported hypothesis of a correlation between ova
output and pathological urine findings has so far been based
upon a urine analysis using reagent strip tests to assess PU, EU,
and LU [2, 31. However, these tests are semiquantitative only,
and accuracy is limited by a number of interfering agents [20].
The main disadvantage of the previously used reagent strip
index [2] for differentiating physiological from pathological
urinary findings in patients with urinary schistosomiasis is the
relatively rough score which renders the interpretation of
individual results difficult. These limiting factors of reagent strip
tests were eliminated in the present study by using quantitative
measurements. The only other quantitative data so far reported
were provided by Dukes et al. [21] who found a correlation
between LU and urinary ova output similar to the one reported
here. The close correlation between urinary ova output and
pathological urine findings as assessed quantitatively thus pro-
vides the basis for the use of reagent strips as an indirect
diagnostic tool in screening programs for urinary schistosomi-
asis.
The origin of PU in urinary schistosomiasis has so far been
controversial. Glomerular changes have been incriminated as a
source of PU [9, 22, 23], possibly on the basis of immune
complex glomerulonephritis [61. These results contrast with
those of other authors [24, 25] who found no significant asso-
ciation between urinary schistosomiasis and nephrotic syn-
drome. Nenna, Bouvry, and Delon [26] considered chronic
renal insufficiency due to glomerulonephritis and interstitial
nephritis to be an exceptional presentation of the disease. Mott
et al [3] showed that the level of PU was related to the intensity
of infection and a postrenal origin was therefore suggested. This
is in accordance with Wilcocks and Manson-Bahr [27] who
regarded the PU of up to three grams per liter as loss from the
bladder wall. Radiographic as well as postmortem studies
demonstrated the primary involvement of the bladder and lower
ureter in urinary schistosomiasis [28, 29].
The present data indicate that the associated pathological PU
may be of postrenal origin. A glomerular PU appears to be most
unlikely because of the results of SDS-PAGE analysis: the
albumin/transferrin ratio in the urine was equal to that in the
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Fig. 1. Linear correlation between PU (A), EU (B), LU(C) and ova
excretion in the urine (N = 182).
indicative of transglomerular blood loss, were detected in only
a minority of total erythrocytes.
Along with the diminution of urinary ova output, pathological
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Fig. 2. The characterization of urinary proteins according to their molecular weight shows a pattern similar to the one in the serum.
Table 2. Results of ova output and urine findings before and 1 month after therapy for four different groups categorized according to
pharmacological therapy
Group A(N = 56)
Group B
(N 42)
Group C(N = 58)
Group D(N = 26)
BT AT BT AT BT AT BT AT
Ova excretion, 68 0.9 106 0.5 54 49 140 72
per 10 ml urine 39 to 125 0.2 to 2.8 38 to 315 0.1 to 1.5 24 to 166 22 to 80 14 to 263 24 to 243
Ova excretion, 744 0 542 610 698 0 680 675
perg stool 581 to 836 0 toO 462 to 722 345 to 790 537 to 823 0 to 10 365 to 1338 265 to 1150
Proteinuria, g 0.42 0.09 0.44 0.09 0.26 0.32 0.24 0.32
per liter 0.22 to 0.62 0.05 to 0.12 0.2 to 0.73 0.07 to 0.15 0.11 to 0.56 0.21 to 0.46 0.09 to 0.59 0.14 to 0.35
Erythrocyturia, 159 1 503 31 241 96 290 323
perpi 34 to 627 0 to 2 72 to 930 ito 112 21 to 873 36 to 384 54 to 1224 51 to 864
Leukocyturia, 144 4 264 19 117 173 145 161
per 1.d 54 to 296 1 to 13 72 to 645 3 to 50 30 to 246 65 to 300 22 to 457 57 to 268
Definitions are: Group A, treated with Praziquantel; Group B, treated with Metrifonate; Group C, treated with Oxamniquine; and Group D,
treated with vitamins as placebo.
Numbers indicate medians and 95% confidence limits.
Abbreviations are: BT, before therapy; AT, one month after therapy.
serum; second, a protein band of around 45,000 daltons ap-
peared, which can be found with postrenal serum leakage [30].
Tubular PU could be ruled out by the absence of typical low
molecular weight proteins in the urine [311. The close correla-
tion between rapid reverse of urinary egg excretion and PU
after treatment, as also reported by Wilkins et al. [4], favors
postrenal PU. However, I month post treatment PU had not yet
reverted to normal, despite the fact that ova output was
comparable to those patients who initially presented with PU
less than 100 mg/liter before therapy. It can be suggested that
PU in heavily infected patients may not only be caused by ova
penetration but also by bladder lesions which may take longer
to heal.
The association between glomerulonephritis and S. mansoni
infection seems to be established [321. Yet, the pathogenic
mechanism remains unclear, and it may well be that immune
complex glomerulonephritis occurs in patients with liver fi-
brosis and portal hypertension only [32, 33]. The pathogenesis
may be comparable in part to the IgA-glomerulonephritis that
occurs in patients with alcohol toxic liver cirrhosis and portal
hypertension [34]. None of the patients reported here had liver
cirrhosis and portal hypertension as proven by clinical and
laboratory data. Species-specific treatment of S. mansoni par-
asites with Oxamniquine did not influence the urinary protein
loss or excretion of cells in the urine. Thus it was concluded
that the concomitant S. mansoni infection in our patients did
not contribute substantially to PU, EU, and LU.
The close correlation between urinary ova output and PU
suggests that PU may be caused directly by penetration of ova
through the bladder mucosa. This is supported by the temporal
relation between circadian variation of ova excretion and PU
[35] and the cystoscopical findings of Abdel-Salam and Ehsan
524 Doehring et a!
Table 3. Results of parasitological and urine analyses of patients with
heavy PU (N = 23)
Before
therapy
One month
post therapy
Five months
post therapy
Ova excretion, 1257 5.4 2.8
per 10 ml 516 to 1824
113to9009
3.4 to 22
Oto9O
1.2 to 7.7
0to24
Erythrocyturia, 4608 144 Not done
peru! 1296to8640
510 to 17481
57to417
Ito 2706
Leukocyturia, 1329 162 Not done
per 1.d 822 to 2520
264 to 7632
22 to 249
0 to 1080
Proteinuria, 2.17 0.18 0.07
g per liter 1.79 to 2.88
1.01 to 6.37
0.06 to 0.31
0.02 to 1.89
0.04 to 0.17
0.02 to 1.33
a PU in excess of 1 g per liter urine.
Numbers represent medians, 95% confidence limits, and ranges,
respectively.
For technical reasons, quantitative urine analysis was not conducted
at 5 months post therapy.
[36] who discovered that the severity of vesical lesions was
related directly to the intensity of infection.
The postrenal origin of erythrocytes as demonstrated by
phase contrast microscopy [13] also supports the hypothesis of
a lack of primary renal damage in urinary schistosomiasis.
Leukocyturia is common in the first years of urinary schisto-
somiasis [37), but is an unusual finding in the later stages of the
disease [38]. The association between urinary schistosomiasis
and urinary tract infection is still discussed controversially [39].
Nitrite, which indicates about 50% of all urinary tract infections
[40], was negative in nearly all our patients, rendering urinary
tract infection of a significant degree most unlikely.
The absence of severe renal impairment in this study, as
compared to other authors who found serious kidney lesions in
patients with schistosomiasis, has to be viewed with the follow-
ing criticisms: the results of different studies cannot be com-
pared directly since area, local transmission dynamics, and
stratification of the studies were different. For example,
Sabbour, El-Said, and Abou-Gabal [7) conducted their study in
a hospital, whereas schoolboys were examined in their native
environment in this study. Furthermore, our patients may have
been too young to have developed serious renal disease.
In conclusion, the present study on pathological urine find-
ings in schoolboys with mixed Schistosoma haematobium and
mansoni infection indicates that abnormalities may be of
postrenal origin and be caused by urinary egg excretion. Severe
renal disease, such as glomerulonephritis or nephrotic syn-
drome, did not occur in these patients.
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